Vanguard Group Inc Ocugen, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 16,619,093 shares of OCGN stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,619,093
Previous 16,949,019
1.95%
Holding current value
$11.3 Million
Previous $16.8 Million
20.76%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding OCGN
# of Institutions
123Shares Held
68.6MCall Options Held
478KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$12.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.59MShares$4.48 Million0.0% of portfolio
-
State Street Corp Boston, MA5.87MShares$3.99 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.67 Million0.1% of portfolio
-
Northern Trust Corp Chicago, IL2.41MShares$1.64 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $147M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...